Journal of Child Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vigevano, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vigevano, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Child Neurology, Vol. 20, No. 2, 87-93 (2005)
DOI: 10.1177/08830738050200020101

Reviews

Topical Review: Levetiracetam in Pediatrics

Federico Vigevano, MD

Neurology Division, Bambino Gesù Children's Hospital, Rome, Italy, vigevano@opbg. net

Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. Few studies are available in children. This review, based on the international literature, aims to identify and make known the possible indications for levetiracetam in childhood. Most studies suggest that levetiracetam is effective against partial and generalized epilepsy. In resistant partial epilepsy, the percentage of responders reaches 64%, with 8 to 23% seizure free. Levetiracetam is used to treat symptomatic and idiopathic epilepsies. The drug has also proven effective against photosensitivity and epileptic and nonepileptic myoclonus. The most frequent side effects involve the behavioral sphere and manifest mostly in patients with a history of behavioral problems. In some patients, levetiracetam increases the number of seizures, but this adverse reaction can be partially avoided with slow titration. Doses for children should be 130 to 140% of those advised for adults. Levetiracetam seems to have a broad spectrum of action and is, on the whole, well tolerated. Its efficacy against generalized epilepsy is particularly promising in childhood. (J Child Neurol 2005;20:87—93).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
M. A. Mikati, D. El Banna, D. Sinno, and S. Mroueh
RESPONSE OF INFANTILE SPASMS TO LEVETIRACETAM
Neurology, February 12, 2008; 70(7): 574 - 575.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
M. P. DiFazio, L. Braun, S. Freedman, and P. Hickey
Rotavirus-Induced Seizures in Childhood
J Child Neurol, December 1, 2007; 22(12): 1367 - 1370.
[Abstract] [PDF]

Home page
 Journal of the American Animal Hospital AssociationHome page
S. Platt, Y. L. McGrotty, C. J. Abramson, and C. Jakobs
Refractory Seizures Associated With an Organic Aciduria in a Dog
J. Am. Anim. Hosp. Assoc., May 1, 2007; 43(3): 163 - 167.
[Abstract] [Full Text] [PDF]